首页 | 官方网站   微博 | 高级检索  
     

肾复康治疗肾病综合征的临床研究
引用本文:汤水福,洪钦国.肾复康治疗肾病综合征的临床研究[J].广州中医药大学学报,2000,17(2):134-136.
作者姓名:汤水福  洪钦国
作者单位:广州中医药大学第一附属医院肾内科,广州,510405
基金项目:国家中医药管理局科研基金! (95B133)
摘    要:为观察肾复康(由雷公藤、黄芪、三七、益母草、山茱萸、茵陈等中药组成)对原发性肾病综合征的临床疗效、副作用,采用前瞻性随机对照方法,观察肾复康对肾病综合征患者(70例)24h尿蛋白定量、血清白蛋白、胆固醇、肌酐和尿素氮等的影响,以及不同中医证型疗效的差别,并与30例雷公藤多甙对照组进行比较。结果:肾复康组完全缓解16例(14.3%)吸效28例(40%),无效16例(36.7%),总有效率为77.1%

关 键 词:肾病综合征  中医药疗法  肾复康  临床研究

Effect of Shenfukang on Nephrotic Syndrome
TANG Shuifu,HONG Qinguo.Effect of Shenfukang on Nephrotic Syndrome[J].Journal of Guangzhou University of Traditional Chinese Medicine,2000,17(2):134-136.
Authors:TANG Shuifu  HONG Qinguo
Abstract:To investigate the curative effect and its side effect of Shenfukang,the effect of Shenfukang on 24hr urine protein,plasma albumin,cholesterol,SCr and BUN,and on different syndromes of TCM was observed in 70 cases of nephrotic syndrome and compared with Tripterygium wilfordii polyglycoside(TWP).Results showed that 16 cases were completely remitted( 22.9% ),10 cases basically remitted ( 14.3% ),28 cases effective(40%),and 16 cases ineffective( 22.9% ),the total effective rate being 77.1% .The levels of 24hr urine protein,plasma albumin,cholesterol,SCr and BUN were improved remarkably after treated with Shenfukang.The differences between before and after treatment were very significant(P< 0.001 ). In TWP group,5 cases were completely remitted( 16.7% ),4 cases basically remitted( 13.3% ),11 cases effective( 36.7% )and 10 cases ineffective( 33.3% ),the total effective rate being 67.7% .The effective rate in Shenfukang group is higher than TWP group,the difference between them is not significant(P> 0.05 ).The side effect and recurrence in Shenfukang group were lower than TWP group.Different syndromes of TCM had different effective rates,that of deficiency of lung_qi and kidney_qi is best,while that of deficiency of liver_yin and kidney_yin is the worst,but the differences among them were not significant(P> 0.05 ).It is concluded that Shenfukang holds a good curative effect,few side effects and low recurrence of the disease,and is an up_to_date good Chinese patent drug for nephrotic syndrome.
Keywords:NEPHROTIC SYNDROME/TCD ther    @ SHENFUKANG/ther  use  TRIPTERYGIUM WILFORDII/ther  use  ACTIVATING BLOOD  STRENGTHENING SPLEEN
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号